Digital ulcers (DUs) are a frequent and debilitating complication of systemic sclerosis (SSc), affecting approximately 50% to 70% of patients during their disease course.1 These ischemic lesions result from severe microvascular dysfunction and impaired tissue perfusion inherent to the autoimmune vasculopathy underlying SSc pathogenesis.2,3
